Nedira Salzman-Frenkel.
Corporate Officer/Principal bei NEUROSENSE THERAPEUTICS LTD.
Profil
Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.
Aktive Positionen von Nedira Salzman-Frenkel.
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01.03.2022 |
Ehemalige bekannte Positionen von Nedira Salzman-Frenkel.
| Unternehmen | Position | Ende |
|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Vorstandsvorsitzender | 01.10.2021 |
Ausbildung von Nedira Salzman-Frenkel.
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
